Myocarditis

Česká verzia

Authors: A. Uhrinová; M. Kováčová; P. Gavornik
Authors place of work: Prednosta: prof. MUDr. Andrej Dukát, CSc., FESC ; II. Interná klinika LFUK a FNsP Bratislava, Slovensko
Published in the journal: Prakt. Lék. 2010; 90(4): 218-221
Category: Various Specialization

Summary

Myocarditis is defined clinically as inflammation of the heart muscle. The consequences of myocarditis vary widely. It can cause a mild disease without any symptoms that resolves itself, or it may cause chest pain, heart failure, or sudden death. Clinical diagnosis is one of the greatest problems of contemporary cardiology. Reliable, accurate diagnostic tests able to exclude or confirm diagnosis are not yet available. Most often, myocarditis results from common viral infections, less commonly, specific forms of myocarditis may result from other pathogens, toxic or hypersensitivity drug reactions, giant-cell myocarditis, or sarcoidosis. The prognosis and treatment of myocarditis vary according to the cause, clinical features and haemodynamic stability.

Key words:
myocarditis, aetiology, diagnostics, treatment, prognosis.

Zdroje

1. Acosta, A.M., Santos-Buch, C.A. Autoimune myocarditis induced by Trypanosoma cruzi. Circulation 1985, 71, p. 1255-1261.

2. Aretz, H.T., Billingam, M.E., Edwards, W.D. et al. Myocarditis: a histopathologic definition and classification. Am. J. Cardiovas. Pathol. 1987, 1, p. 3-14.

3. Belicová, M. Akútna myokarditída, výskyt, diagnostika a liečba v spádovej nemocnici. Vnitř. Lék. 2005, 51(5), s. 510-517.

4. Cooper, L.T., Baughman, K.L., Feldman, A.M. et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the AHA, ACC, and ESC. Circulation 2007, 116, p. 2216-2233.

5. Dåmas, J.K., Gullestad, L., Aukrust, P. Cytokines as new treatment targets in chronic heart failure. Curr. Control Trials Cardiovasc. Med. 2001, 2, p. 271-277.

6. Davydova, J., Pankuweit, S., Crombach, M. et al. Detection of viral and bacterial protein in endomyocardioal biopsies of patients with inflammatory heart muscle disease? Herz 2000, 25, p. 233-239.

7. Drory, Y., Turetz, Y., Hiss, Y., et al. Sudden death in persons less than 40 years of age. Am. J. Cardiol. 1991, 68, p. 1388-1392.

8. Gavorník, P. Etiopatogenéza a diferenciálna diagnóza edémových stavov. Cardiol. 2009, 18(2), s. 73-78.

9. Wynne, J., Braunwald, E. Cardiomyopathy and myocarditis. In: Kasper D, Braunwald E, Fauci A, et al. (editors). Harrison’s Princples of Internal Medicine. 17th Edition. New York: McGraw-Hill, 2008, p. 1481-1488.

10. Lieberman, E.B., Hutchins, G.M., Herskovitz, A. et al. Clinicopathologic description of myocarditis. J. Am. Coll. Cardiol. 1991, 18, p. 1617-1626.

11. Müllerová J., Novák M., Vítovec J. Myokarditidy. Kardio. Rev. 2003, 5, s. 56-59.

12. Vítovec, J., Lipoldová, J. Myokarditidy. Vnitř. Lék. 2009, 55(9), s. 702-709.